Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028
Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028 (ABLLL) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028 (ABLLL), covering cash flow, earnings, and balance sheets.
Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028 (ABLLL) Income Statement & Financial Overview
View the income breakdown for Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028 ABLLL across both annual and quarterly reports.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $33.21M | $28.15M | $29.93M | $21.49M |
| Cost of Revenue | $3.72M | $2.19M | $4.49M | $4.40M |
| Gross Profit | $29.49M | $25.96M | $25.44M | $17.08M |
| Gross Profit Ratio | $0.89 | $0.92 | $0.85 | $0.80 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $42.75M | $17.66M | $17.11M | $13.28M |
| Operating Expenses | $46.25M | $19.11M | $19.56M | $14.97M |
| Total Costs & Expenses | $49.97M | $21.30M | $22.31M | $18.29M |
| Interest Income | $727863.00 | $609496.00 | $639906.00 | $421426.00 |
| Interest Expense | $5.86M | $4.22M | $4.53M | $3.67M |
| Depreciation & Amortization | $2.73M | $1.75M | $1.75M | $1.68M |
| EBITDA | -$7.61M | $428414.00 | $7.85M | $4.88M |
| EBITDA Ratio | -$0.23 | $0.02 | $0.26 | $0.23 |
| Operating Income | -$16.76M | $6.85M | $6.77M | $3.20M |
| Operating Income Ratio | -$0.50 | $0.24 | $0.23 | $0.15 |
| Other Income/Expenses (Net) | $556553.00 | -$12.39M | -$4.36M | -$3.30M |
| Income Before Tax | -$16.21M | -$5.54M | $2.41M | -$101958.00 |
| Income Before Tax Ratio | -$0.49 | -$0.20 | $0.08 | -$0.005 |
| Income Tax Expense | $2.80M | -$250368.00 | $1.76M | $1.17M |
| Net Income | -$18.26M | -$5.13M | $769983.00 | -$1.35M |
| Net Income Ratio | -$0.55 | -$0.18 | $0.03 | -$0.06 |
| EPS | -$0.29 | -$0.08 | $0.01 | -$0.02 |
| Diluted EPS | -$0.27 | -$0.08 | $0.01 | -$0.02 |
| Weighted Avg Shares Outstanding | $81.78M | $63.85M | $63.85M | $63.03M |
| Weighted Avg Shares Outstanding (Diluted) | $81.78M | $67.16M | $67.16M | $63.03M |
Over the past four quarters, Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028 demonstrated steady revenue growth, increasing from $21.49M in Q1 2024 to $33.21M in Q4 2024. Operating income reached -$16.76M in Q4 2024, maintaining a consistent -50% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$7.61M, reflecting operational efficiency. Net income dropped to -$18.26M, with EPS at -$0.29. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan